Mechanistically, CD9<sup>+</sup>CD55<sup>low</sup> APCs promote T2D development through producing bioactive proteins to form a detrimental niche, leading to upregulation of adipocyte lipolysis. The gene discussed is CD55; the disease is type 2 diabetes mellitus.